chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain, Vaccination site pain
Clinical narrative: sideeffects were very painful; Pain around the injection site; joint pain around the shoulder, pain in rotator cuff and/or joint of left arm/extreme pain in shoulder blade and rotator cuff; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (sideeffects were very painful), VACCINATION SITE PAIN (Pain around the injection site) and ARTHRALGIA (joint pain around the shoulder, pain in rotator cuff and/or joint of left arm/extreme pain in shoulder blade and rotator cuff) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013620A and 015M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Jan-2021, the patient experienced PAIN (sideeffects were very painful), VACCINATION SITE PAIN (Pain around the injection site) and ARTHRALGIA (joint pain around the shoulder, pain in rotator cuff and/or joint of left arm/extreme pain in shoulder blade and rotator cuff). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, PAIN (sideeffects were very painful), VACCINATION SITE PAIN (Pain around the injection site) and ARTHRALGIA (joint pain around the shoulder, pain in rotator cuff and/or joint of left arm/extreme pain in shoulder blade and rotator cuff) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medications were not provided.  Patient has had an MRI and CT scan procedure, results are unknown.  Treatment information included prescription steroid pills discontinued.   This case was linked to MOD21-069007 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 05-Apr-2021: Contains significant information- Patient demographics and Vaccination date for first dose has been updated, event details and treatment information was added. On 28-Apr-2021: Contains significant information- Reporter address and event details has been added. New events for second dose and treatment information added. On 28-Apr-2021: Contains significant information -A new event was added.; Sender's Comments:  MOD21-069007:crosslinked
Sex: M
Vaccine: COVID19
Symptoms: Muscular weakness, Neck pain, Pain in extremity
Clinical narrative: had some pain down his neck; had trouble lifting his left arm yesterday; muscle weakness; This spontaneous case was reported by a pharmacist and describes the occurrence of NECK PAIN (had some pain down his neck), PAIN IN EXTREMITY (had trouble lifting his left arm yesterday) and MUSCULAR WEAKNESS (muscle weakness) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 027L20A) for COVID-19 vaccination.     The patient's past medical history included Neck discomfort.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NECK PAIN (had some pain down his neck), PAIN IN EXTREMITY (had trouble lifting his left arm yesterday) and MUSCULAR WEAKNESS (muscle weakness). At the time of the report, NECK PAIN (had some pain down his neck), PAIN IN EXTREMITY (had trouble lifting his left arm yesterday) and MUSCULAR WEAKNESS (muscle weakness) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 24-Feb-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of NECK PAIN (had some pain down his neck), PAIN IN EXTREMITY (had trouble lifting his left arm yesterday) and MUSCULAR WEAKNESS (muscle weakness) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 027L20A) for COVID-19 vaccination.     The patient's past medical history included Neck discomfort.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NECK PAIN (had some pain down his neck), PAIN IN EXTREMITY (had trouble lifting his left arm yesterday) and MUSCULAR WEAKNESS (muscle weakness). At the time of the report, NECK PAIN (had some pain down his neck), PAIN IN EXTREMITY (had trouble lifting his left arm yesterday) and MUSCULAR WEAKNESS (muscle weakness) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pruritus, Rash, Swelling
Clinical narrative: Delayed type hypersensitivity; Rash; Bumped area; warm; little itchy; red; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (Delayed type hypersensitivity), RASH (Rash), SWELLING (Bumped area), FEELING HOT (warm) and PRURITUS (little itchy) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included SPIRONOLACTONE, AMOXICILLIN TRIHYDRATE, CLARITHROMYCIN, ESOMEPRAZOLE MAGNESIUM (NEXIUM 1-2-3), AMBRISENTAN, TADALAFIL and MULTIVITAMINS & MINERALS PLUS LUTEIN for an unknown indication.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (Delayed type hypersensitivity), RASH (Rash), SWELLING (Bumped area), FEELING HOT (warm), PRURITUS (little itchy) and ERYTHEMA (red). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, TYPE IV HYPERSENSITIVITY REACTION (Delayed type hypersensitivity) had not resolved and RASH (Rash), SWELLING (Bumped area), FEELING HOT (warm), PRURITUS (little itchy) and ERYTHEMA (red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Type IV hypersensitivity reaction
Clinical narrative: Delayed type hypersensitivity; Rash; Bumped area; warm; little itchy; red; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (Delayed type hypersensitivity), RASH (Rash), SWELLING (Bumped area), FEELING HOT (warm) and PRURITUS (little itchy) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included SPIRONOLACTONE, AMOXICILLIN TRIHYDRATE, CLARITHROMYCIN, ESOMEPRAZOLE MAGNESIUM (NEXIUM 1-2-3), AMBRISENTAN, TADALAFIL and MULTIVITAMINS & MINERALS PLUS LUTEIN for an unknown indication.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (Delayed type hypersensitivity), RASH (Rash), SWELLING (Bumped area), FEELING HOT (warm), PRURITUS (little itchy) and ERYTHEMA (red). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, TYPE IV HYPERSENSITIVITY REACTION (Delayed type hypersensitivity) had not resolved and RASH (Rash), SWELLING (Bumped area), FEELING HOT (warm), PRURITUS (little itchy) and ERYTHEMA (red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: fatigue; arm was sore where I got the shot; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) and VACCINATION SITE PAIN (arm was sore where I got the shot) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical history information was reported.     On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced FATIGUE (fatigue) and VACCINATION SITE PAIN (arm was sore where I got the shot). At the time of the report, FATIGUE (fatigue) and VACCINATION SITE PAIN (arm was sore where I got the shot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Feb-2021 and was forwarded to Moderna on 08-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) and VACCINATION SITE PAIN (arm was sore where I got the shot) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical history information was reported.     On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced FATIGUE (fatigue) and VACCINATION SITE PAIN (arm was sore where I got the shot). At the time of the report, FATIGUE (fatigue) and VACCINATION SITE PAIN (arm was sore where I got the shot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vaccination site reaction
Clinical narrative: a bad reaction; high fever; her whole body hurts; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (a bad reaction), PYREXIA (high fever) and PAIN (her whole body hurts) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (a bad reaction), PYREXIA (high fever) and PAIN (her whole body hurts). At the time of the report, VACCINATION SITE REACTION (a bad reaction), PYREXIA (high fever) and PAIN (her whole body hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Contracted covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Contracted covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was reported.     On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Contracted covid-19). At the time of the report, COVID-19 (Contracted covid-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Feb-2021 and was forwarded to Moderna on 24-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Contracted covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was reported.     On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Contracted covid-19). At the time of the report, COVID-19 (Contracted covid-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Nausea, Pyrexia, Restless legs syndrome, Vaccination site pain
Clinical narrative: Wobbly legs; Fell once; Tenderness on left arm; Nausea; Little fever; This spontaneous case was reported by a consumer and describes the occurrence of FALL (Fell once) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004MZ0A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced FALL (Fell once). At the time of the report, FALL (Fell once) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: tingling in left shoulder to neck; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling in left shoulder to neck) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PARAESTHESIA (tingling in left shoulder to neck). At the time of the report, PARAESTHESIA (tingling in left shoulder to neck) was resolving.            Concomitant products included unspecified medicines to treat blood pressure, cholesterol and diabetes.  The patient reported the tingling she felt after second shot was coming and going at the time of follow-up information received. She reported it had been days since last felt the sensation. The patient reported that her PCP believed the tingling was more a result of a pinched nerve and possibly not related to the vaccine.     No Treatment information for the event was provided.   This case was linked to MOD21-14861 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Update the start date of first dose of vaccine and Event outcome for Paresthesia is recovering; Sender's Comments:  MOD21-14861:First case received on 24-Jan-2021
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered to a patient from pre-filled syringe as original vial had been punctured 16 hours prior to administration; A spontaneous report was received from a nurse concerning an unknown age  old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273 ) and experienced expired product administered.  The patient's medical history was not provided.  Concomitant product use was not provided by the reporter.    On an unknown date, the patient received their first of two planned doses of mRNA-1273 (Batch number: unknown) for prophylaxis of COVID-19 infection. Patient received the vaccine from a prefilled syringe and the original vial had been punctured 16 hours prior to administration and was kept at room temperature during that period of time.  Treatment information was not provided/unknown.   Action taken with mRNA-1273 in response to the event was not provided.  The outcome of event was resolved.; Reporter's Comments: This case concerns a female patient of unknown age who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting Expired product administered without any associated adverse events.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Nausea, Pruritus
Clinical narrative: Body itching; Tenderness at site of injection; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Body itching), INJECTION SITE PAIN (Tenderness at site of injection) and NAUSEA (Nausea) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced PRURITUS (Body itching), INJECTION SITE PAIN (Tenderness at site of injection) and NAUSEA (Nausea). On 24-Feb-2021, PRURITUS (Body itching) and NAUSEA (Nausea) had resolved and INJECTION SITE PAIN (Tenderness at site of injection) outcome was unknown.            Concomitant product use was not provided by the reporter.  No treatment medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Added outcome of the events
Age: 73.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Erythema, Pain in extremity, Pruritus, Rash
Clinical narrative: soreness on right arm; itchiness; redness at injection site; rash; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness on right arm), PRURITUS (itchiness), ERYTHEMA (redness at injection site) and RASH (rash) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product CORTISONE for an unknown indication.    Concurrent medical conditions included Drug allergy (Tromethamine).   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started CORTISONE (unknown route) at an unspecified dose. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (soreness on right arm), PRURITUS (itchiness), ERYTHEMA (redness at injection site) and RASH (rash). On 02-Feb-2021, PAIN IN EXTREMITY (soreness on right arm) outcome was unknown. At the time of the report, PRURITUS (itchiness), ERYTHEMA (redness at injection site) and RASH (rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Cortisone.   Reporter did not allow further contact
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included ATORVASTATIN for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm pain). On 03-Feb-2021, PAIN IN EXTREMITY (Arm pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow-up received on 13-JUL-2021 contains non significant information.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Nausea, Vaccination site pain
Clinical narrative: metallic taste in her mouth; left arm is sore and tender at the injection site; little nausea; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (metallic taste in her mouth), VACCINATION SITE PAIN (left arm is sore and tender at the injection site) and NAUSEA (little nausea) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced DYSGEUSIA (metallic taste in her mouth), VACCINATION SITE PAIN (left arm is sore and tender at the injection site) and NAUSEA (little nausea). On 05-Feb-2021, VACCINATION SITE PAIN (left arm is sore and tender at the injection site) outcome was unknown. At the time of the report, DYSGEUSIA (metallic taste in her mouth) and NAUSEA (little nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: No specific follow-up information recorded.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: Injection site got swollen; Injection site got red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Injection site got swollen) and VACCINATION SITE ERYTHEMA (Injection site got red) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Injection site got swollen) and VACCINATION SITE ERYTHEMA (Injection site got red). At the time of the report, VACCINATION SITE SWELLING (Injection site got swollen) and VACCINATION SITE ERYTHEMA (Injection site got red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment details were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Cough, Ear pain, Fatigue, Oral herpes, Oropharyngeal pain
Clinical narrative: Ear pain in right ear; Cold sores on right side of mouth; Throat was hurting; Sinus pressure under right eye; Cough; Aches; Fatigue; Fevers ranging from 98.5-102.5F; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (Ear pain in right ear), ORAL HERPES (Cold sores on right side of mouth), OROPHARYNGEAL PAIN (Throat was hurting), PARANASAL SINUS DISCOMFORT (Sinus pressure under right eye) and COUGH (Cough) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EAR PAIN (Ear pain in right ear), ORAL HERPES (Cold sores on right side of mouth), OROPHARYNGEAL PAIN (Throat was hurting), PARANASAL SINUS DISCOMFORT (Sinus pressure under right eye), COUGH (Cough), PAIN (Aches), FATIGUE (Fatigue) and PYREXIA (Fevers ranging from 98.5-102.5F). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, EAR PAIN (Ear pain in right ear), ORAL HERPES (Cold sores on right side of mouth), OROPHARYNGEAL PAIN (Throat was hurting), PARANASAL SINUS DISCOMFORT (Sinus pressure under right eye), COUGH (Cough), PAIN (Aches), FATIGUE (Fatigue) and PYREXIA (Fevers ranging from 98.5-102.5F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Feb-2021, SARS-CoV-2 test: positive (Positive) reports testing positive for COVID-19 on 7Feb2021. In 2021, Pyrexia: 98.5-102.5f (abnormal) Fevers ranging from 98.5-102.5F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. In addition to paracetamol, patient reported taking fluids for treatment.
Sex: M
Vaccine: COVID19
Symptoms: Pain, Paranasal sinus discomfort, Pyrexia, SARS-CoV-2 test
Clinical narrative: Ear pain in right ear; Cold sores on right side of mouth; Throat was hurting; Sinus pressure under right eye; Cough; Aches; Fatigue; Fevers ranging from 98.5-102.5F; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (Ear pain in right ear), ORAL HERPES (Cold sores on right side of mouth), OROPHARYNGEAL PAIN (Throat was hurting), PARANASAL SINUS DISCOMFORT (Sinus pressure under right eye) and COUGH (Cough) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EAR PAIN (Ear pain in right ear), ORAL HERPES (Cold sores on right side of mouth), OROPHARYNGEAL PAIN (Throat was hurting), PARANASAL SINUS DISCOMFORT (Sinus pressure under right eye), COUGH (Cough), PAIN (Aches), FATIGUE (Fatigue) and PYREXIA (Fevers ranging from 98.5-102.5F). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, EAR PAIN (Ear pain in right ear), ORAL HERPES (Cold sores on right side of mouth), OROPHARYNGEAL PAIN (Throat was hurting), PARANASAL SINUS DISCOMFORT (Sinus pressure under right eye), COUGH (Cough), PAIN (Aches), FATIGUE (Fatigue) and PYREXIA (Fevers ranging from 98.5-102.5F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Feb-2021, SARS-CoV-2 test: positive (Positive) reports testing positive for COVID-19 on 7Feb2021. In 2021, Pyrexia: 98.5-102.5f (abnormal) Fevers ranging from 98.5-102.5F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. In addition to paracetamol, patient reported taking fluids for treatment.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: it was red; was Itchy; Rash appeared at several locations on his body; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (it was red), PRURITUS (was Itchy) and RASH (Rash appeared at several locations on his body) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes mellitus insulin-dependent. Concomitant products included METFORMIN, VITAMINS NOS, CURCUMA LONGA (TURMERIC [CURCUMA LONGA]), RAMIPRIL, ATORVASTATIN, RIVAROXABAN (XARELTO) and INSULIN for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced ERYTHEMA (it was red), PRURITUS (was Itchy) and RASH (Rash appeared at several locations on his body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event following immunisation, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (ANTI ITCH CREAM [DIPHENHYDRAMINE HYDROCHLORIDE]) (topical) for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, ERYTHEMA (it was red), PRURITUS (was Itchy) and RASH (Rash appeared at several locations on his body) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site reaction, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Injection site big; Injection site hot; Injection site red; Injection site sore; COVID arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Injection site big), VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE ERYTHEMA (Injection site red), VACCINATION SITE PAIN (Injection site sore) and VACCINATION SITE REACTION (COVID arm) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Injection site big), VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE ERYTHEMA (Injection site red), VACCINATION SITE PAIN (Injection site sore) and VACCINATION SITE REACTION (COVID arm). At the time of the report, VACCINATION SITE SWELLING (Injection site big), VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE ERYTHEMA (Injection site red), VACCINATION SITE PAIN (Injection site sore) and VACCINATION SITE REACTION (COVID arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.    No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-024106, US-MODERNATX, INC.-MOD-2021-024767 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-024106:MOD21-023085 US-MODERNATX, INC.-MOD-2021-024767:
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pain
Clinical narrative: body ache for 2 weeks; chills for 2 weeks; muscle pain for 2 weeks; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body ache for 2 weeks), CHILLS (chills for 2 weeks) and MYALGIA (muscle pain for 2 weeks) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN (body ache for 2 weeks), CHILLS (chills for 2 weeks) and MYALGIA (muscle pain for 2 weeks). At the time of the report, PAIN (body ache for 2 weeks), CHILLS (chills for 2 weeks) and MYALGIA (muscle pain for 2 weeks) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information was reported. Treatment information was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product IMMUNOGLOBULIN HUMAN NORMAL (HIZENTRA) for Common variable immunodeficiency.    No medical history was reported.    In 2014, the patient started IMMUNOGLOBULIN HUMAN NORMAL (HIZENTRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurt). At the time of the report, PAIN IN EXTREMITY (arm hurt) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No Treatment information was  provided.    Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Soreness of upper arm left; Internittent headaches for 48 hours; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Soreness of upper arm left) and HEADACHE (Internittent headaches for 48 hours) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness of upper arm left) and HEADACHE (Internittent headaches for 48 hours). At the time of the report, PAIN IN EXTREMITY (Soreness of upper arm left) and HEADACHE (Internittent headaches for 48 hours) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication included Acetaminophen and light activity. No concomitant medication was provided
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fear, Headache, Illness, Pyrexia
Clinical narrative: Scared; Fever, today 99.2 degree F, was sick in bed 3 days with 102.8 degree F; Sick; Dizziness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), ILLNESS (Sick), FEAR (Scared), PYREXIA (Fever, today 99.2 degree F, was sick in bed 3 days with 102.8 degree F) and HEADACHE (Headache) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Fibromyalgia.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced DIZZINESS (Dizziness) and HEADACHE (Headache). On 27-Jan-2021, the patient experienced ILLNESS (Sick) and PYREXIA (Fever, today 99.2 degree F, was sick in bed 3 days with 102.8 degree F). On an unknown date, the patient experienced FEAR (Scared). At the time of the report, DIZZINESS (Dizziness), ILLNESS (Sick), FEAR (Scared), PYREXIA (Fever, today 99.2 degree F, was sick in bed 3 days with 102.8 degree F) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment details included advicodid, acetaminophen, aspirin, caffeine .
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Dyspepsia, Flatulence, Pain in extremity
Clinical narrative: stomach problems, pain; stomach burning; gas; arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach problems, pain), DYSPEPSIA (stomach burning), FLATULENCE (gas) and PAIN IN EXTREMITY (arm hurt) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder and Allergy.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm hurt). On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (stomach problems, pain), DYSPEPSIA (stomach burning) and FLATULENCE (gas). On 30-Jan-2021, PAIN IN EXTREMITY (arm hurt) had resolved. At the time of the report, ABDOMINAL PAIN UPPER (stomach problems, pain), DYSPEPSIA (stomach burning) and FLATULENCE (gas) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were Allergies medication, Thyroids pills for drug use for unknown indication. Treatment medications includes Tums, antacids and Nexium. Patient Went to see GI doctor did endoscopy she was on special diet and checked gall bladder.    This case was linked to US-MODERNATX, INC.-MOD-2021-048047 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow up contains treatment details updated and new events were updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-048047:Second dose
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: redness at the injection site; Swelling at site of injection; some pain at the injection site; itching at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (redness at the injection site), INJECTION SITE SWELLING (Swelling at site of injection), INJECTION SITE PAIN (some pain at the injection site) and INJECTION SITE PRURITUS (itching at the injection site) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (redness at the injection site), INJECTION SITE SWELLING (Swelling at site of injection), INJECTION SITE PAIN (some pain at the injection site) and INJECTION SITE PRURITUS (itching at the injection site). At the time of the report, INJECTION SITE ERYTHEMA (redness at the injection site), INJECTION SITE SWELLING (Swelling at site of injection), INJECTION SITE PAIN (some pain at the injection site) and INJECTION SITE PRURITUS (itching at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitant medications reported. no treatment details reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: TCR received,patient reported events settled in 3 days and also received second dose.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Dizziness, Fatigue
Clinical narrative: Big lump on the arm that is numb; big lump on the arm that is numb; Red mark and the size of a baseball; sore arm; Tired; Headache; a lot of muscle pain; Joint pain; Chills; Dizziness; Weakness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Big lump on the arm that is numb), HYPOAESTHESIA (big lump on the arm that is numb), VACCINATION SITE ERYTHEMA (Red mark and the size of a baseball), VACCINATION SITE PAIN (sore arm) and FATIGUE (Tired) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse reaction.    On 04-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (Big lump on the arm that is numb), HYPOAESTHESIA (big lump on the arm that is numb), VACCINATION SITE ERYTHEMA (Red mark and the size of a baseball), VACCINATION SITE PAIN (sore arm), FATIGUE (Tired), HEADACHE (Headache), MYALGIA (a lot of muscle pain), ARTHRALGIA (Joint pain), CHILLS (Chills), DIZZINESS (Dizziness) and ASTHENIA (Weakness). At the time of the report, VACCINATION SITE MASS (Big lump on the arm that is numb), HYPOAESTHESIA (big lump on the arm that is numb), VACCINATION SITE ERYTHEMA (Red mark and the size of a baseball), VACCINATION SITE PAIN (sore arm), FATIGUE (Tired), HEADACHE (Headache), MYALGIA (a lot of muscle pain), ARTHRALGIA (Joint pain), CHILLS (Chills), DIZZINESS (Dizziness) and ASTHENIA (Weakness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information provided. No treatment information provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Myalgia, Vaccination site erythema, Vaccination site mass
Clinical narrative: Big lump on the arm that is numb; big lump on the arm that is numb; Red mark and the size of a baseball; sore arm; Tired; Headache; a lot of muscle pain; Joint pain; Chills; Dizziness; Weakness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Big lump on the arm that is numb), HYPOAESTHESIA (big lump on the arm that is numb), VACCINATION SITE ERYTHEMA (Red mark and the size of a baseball), VACCINATION SITE PAIN (sore arm) and FATIGUE (Tired) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse reaction.    On 04-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (Big lump on the arm that is numb), HYPOAESTHESIA (big lump on the arm that is numb), VACCINATION SITE ERYTHEMA (Red mark and the size of a baseball), VACCINATION SITE PAIN (sore arm), FATIGUE (Tired), HEADACHE (Headache), MYALGIA (a lot of muscle pain), ARTHRALGIA (Joint pain), CHILLS (Chills), DIZZINESS (Dizziness) and ASTHENIA (Weakness). At the time of the report, VACCINATION SITE MASS (Big lump on the arm that is numb), HYPOAESTHESIA (big lump on the arm that is numb), VACCINATION SITE ERYTHEMA (Red mark and the size of a baseball), VACCINATION SITE PAIN (sore arm), FATIGUE (Tired), HEADACHE (Headache), MYALGIA (a lot of muscle pain), ARTHRALGIA (Joint pain), CHILLS (Chills), DIZZINESS (Dizziness) and ASTHENIA (Weakness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information provided. No treatment information provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Big lump on the arm that is numb; big lump on the arm that is numb; Red mark and the size of a baseball; sore arm; Tired; Headache; a lot of muscle pain; Joint pain; Chills; Dizziness; Weakness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Big lump on the arm that is numb), HYPOAESTHESIA (big lump on the arm that is numb), VACCINATION SITE ERYTHEMA (Red mark and the size of a baseball), VACCINATION SITE PAIN (sore arm) and FATIGUE (Tired) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse reaction.    On 04-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (Big lump on the arm that is numb), HYPOAESTHESIA (big lump on the arm that is numb), VACCINATION SITE ERYTHEMA (Red mark and the size of a baseball), VACCINATION SITE PAIN (sore arm), FATIGUE (Tired), HEADACHE (Headache), MYALGIA (a lot of muscle pain), ARTHRALGIA (Joint pain), CHILLS (Chills), DIZZINESS (Dizziness) and ASTHENIA (Weakness). At the time of the report, VACCINATION SITE MASS (Big lump on the arm that is numb), HYPOAESTHESIA (big lump on the arm that is numb), VACCINATION SITE ERYTHEMA (Red mark and the size of a baseball), VACCINATION SITE PAIN (sore arm), FATIGUE (Tired), HEADACHE (Headache), MYALGIA (a lot of muscle pain), ARTHRALGIA (Joint pain), CHILLS (Chills), DIZZINESS (Dizziness) and ASTHENIA (Weakness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information provided. No treatment information provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure decreased
Clinical narrative: Blood pressure dropped really low 77/58; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE DECREASED (Blood pressure dropped really low 77/58) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported history.).    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced BLOOD PRESSURE DECREASED (Blood pressure dropped really low 77/58). On 18-Jan-2021, BLOOD PRESSURE DECREASED (Blood pressure dropped really low 77/58) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information provided. No treatment information provided.